Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1052 | 990 | 1116 | 958 | 1013 | 1504 |
Fund Return | 5.22% | -1.01% | 11.6% | -1.41% | 0.27% | 4.16% |
Place in category | 606 | 399 | 586 | 560 | 473 | 325 |
% in Category | 97 | 64 | 94 | 100 | 99 | 91 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Income Fund X Accumulation | 87.11M | 11.63 | 10.25 | 11.42 | ||
NG Fund Institutional Accumulation | 125.28M | 10.60 | 9.15 | 10.32 | ||
Income Fund B Accumulation | 16.02M | 10.71 | 9.26 | 10.40 | ||
NG Income Fund Institutional Income | 247.07K | 10.60 | 9.16 | 10.32 | ||
Income Fund B Income | 52.68M | 10.71 | 9.27 | 10.41 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 14.77B | 11.13 | 7.80 | 6.10 | ||
All Share Index Unit Trust Income | 14.77B | 11.14 | 7.78 | 6.09 | ||
VG UK Plus GBP Accumulation | 14.77B | 11.14 | 7.80 | 6.12 | ||
VG UK Institutional Plus GBP Income | 14.77B | 11.15 | 7.79 | 6.11 | ||
UK Equity Tracker Fund D Acc | 11.69B | 10.48 | 8.11 | 6.25 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Unilever | GB00B10RZP78 | 6.05 | 56.50 | +0.68% | |
AstraZeneca | GB0009895292 | 5.97 | 10,524.0 | +0.53% | |
GSK plc | GB00BN7SWP63 | 5.27 | 1,319.50 | -0.75% | |
London Stock Exchange | GB00B0SWJX34 | 4.85 | 11,515.0 | +1.10% | |
Compass | GB00BD6K4575 | 4.62 | 2,655.00 | -0.26% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Strong Buy | Strong Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review